Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

Clinical trial NCT00839982 · COMPLETED

Trial details

NCT number: NCT00839982
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Myelodysplastic Syndrome With Isolated Del(5q)Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia

Start date: 2008-11-01
Primary completion: 2012-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.